**Core Concept**
The question tests the student's knowledge of opioid potency, which is crucial for clinical decision-making in pain management and anesthesia. Opioid potency is determined by their ability to bind to opioid receptors, specifically the mu (μ) receptor, which is responsible for their analgesic effects.

**Why the Correct Answer is Right**
Sufentanil and fentanyl are both potent opioids that bind strongly to the mu receptor. Sufentanil has a higher affinity for the mu receptor than fentanyl, making it the most potent opioid among the options. Morphine, on the other hand, has a lower potency compared to sufentanil and fentanyl due to its lower affinity for the mu receptor. Pethidine (also known as meperidine) has a different mechanism of action and is not as potent as the other opioids listed.

**Why Each Wrong Option is Incorrect**
**Option A:** Fentanyl is a potent opioid, but it is less potent than sufentanil. Therefore, it should not be listed first.
**Option C:** Morphine is less potent than both sufentanil and fentanyl, making it the least potent option among the four.
**Option D:** Pethidine is a different class of opioid and is not as potent as the mu receptor agonists listed (sufentanil, fentanyl, and morphine).

**Clinical Pearl / High-Yield Fact**
When choosing an opioid for pain management, it's essential to consider the patient's underlying medical conditions, such as respiratory disease, and the potential for opioid-induced respiratory depression. The potency of the opioid should be carefully matched to the patient's needs to minimize the risk of adverse effects.

**Correct Answer:** b. Sufentanil